Phase 3 Bone Sarcoma Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas

Bone SarcomaEmbryonal RhabdomyosarcomaAlveolar Rhabdomyosarcoma

N.N. Petrov National Medical Research Center of Oncology40 enrolled1 locationNCT06669013

Recruiting

Phase 3

A Pivotal Trial to Determine the Efficacy and Safety of AP23573 when Administered as Maintenance Therapy to Patients with Metastatic Soft Tissue or Bone Sarcomas.

Metastatic soft tissue or bone sarcomas

ARIAD Pharmaceuticals, Inc.650 enrolled26 locationsACTRN12608000214336